Basic Information
Basic information for C5orf64-210-21aa
Peptide Name C5orf64-210-21aa
Genome Position chr5:61705372-61705434[+]
Species Human
Peptide Sequence MNLDSQKVNQESIQNGVPLAE
Peptide Length 21
Unique No (C5orf64-201-21aa,C5orf64-203-21aa,C5orf64-211-21aa,C5orf64-213-21aa,C5orf64-215-21aa,C5orf64-225-21aa)
Grand Average of Hydropathicity -0.7048
Relative Molecular Mass 2674.85
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000178722;C5orf64
Transcript ID/Name ENST00000657803;C5orf64-210
Transcript Length 3163
Coding Ability 0.3791
DNA Sequence Corresponding to Peptide ATGAACTTAGATTCACAGAAAGTAAATCAAGAATCCATCCAAAATGGAGTGCCTCTTGCTGAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :